Literature DB >> 12271009

Circulating osteoprotegerin is not removed through haemodialysis membrane.

Junichiro J Kazama, Hitoshi Kato, Tetsuhiko Sato, Takashi Shigematsu, Masafumi Fukagawa, Yoshiko Iwasaki, Fumitake Gejyo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12271009     DOI： 10.1093/ndt/17.10.1860

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  4 in total

Review 1.  Muscle-Bone Crosstalk in Chronic Kidney Disease: The Potential Modulatory Effects of Exercise.

Authors:  Diogo V Leal; Aníbal Ferreira; Emma L Watson; Kenneth R Wilund; João L Viana
Journal:  Calcif Tissue Int       Date:  2021-01-02       Impact factor: 4.333

2.  Serum osteoprotegerin, RANKL and fibroblast growth factor-23 in children with chronic kidney disease.

Authors:  Ekaterini Siomou; Anna Challa; Nikoleta Printza; Vasileios Giapros; Fotini Petropoulou; Andromachi Mitsioni; Fotios Papachristou; Constantinos J Stefanidis
Journal:  Pediatr Nephrol       Date:  2011-04-09       Impact factor: 3.714

3.  sRANKL/osteoprotegerin complex and biochemical markers in a cohort of male and female hemodialysis patients.

Authors:  K K Doumouchtsis; A I Kostakis; S K Doumouchtsis; M P Tziamalis; C Tsigris; M A Kostaki; D N Perrea
Journal:  J Endocrinol Invest       Date:  2007-10       Impact factor: 4.256

Review 4.  The Role of Osteoprotegerin as a Cardioprotective Versus Reactive Inflammatory Marker: the Chicken or the Egg Paradox

Authors:  Flora Özkalaycı; Öykü Gülmez; Betül Uğur-Altun; Seithikurippu Ratnas Pandi-Perumal; Armağan Altun
Journal:  Balkan Med J       Date:  2018-04-24       Impact factor: 2.021
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.